-
Alchemab completes £60m Series A funding to advance novel antibody platform
pharmatimes
April 16, 2021
Cambridge, UK-based Alchemab Therapeutics has raised £60m ($82m) in a Series A funding round, in a bid to advance its target-agnostic drug discovery platform.
-
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
prnasia
January 08, 2021
Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, announced the first closing of an oversubscribed $53.5 million Series B+ financing.
-
Servier and X-Chem Enter Drug Discovery Collaboration
contractpharma
January 08, 2021
Servier, a global pharmaceutical Group, and X-Chem Inc., a privately held drug discovery company, have partnered to identify and develop novel small molecules for the treatment of neurological disorders.
-
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
prnasia
December 21, 2020
Teijin Pharma Limited, the core company of the Teijin Group's healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd., a clinical-stage biotechnology company based in Nanjing, China, jointly announced that they have ...
-
Evotec, BMS Advance Targeted Protein Degradation Projects
contractpharma
December 18, 2020
The first two targets transition into drug discovery after completing a comprehensive target validation process.
-
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
prnasia
December 08, 2020
PostEra announced a strategic partnership with Pfizer Inc. with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
-
Career prospects in pharma in the new normal
expresspharma
December 07, 2020
The manpower needs in the pharma industry are foremost in manufacturing, quality assurance, quality control and sales, followed by other functions like HR, IT, and marketing. In this article, we’ll focus on career prospects in the top key domains of ...
-
BMS inks drug discovery deal with Schrödinger
pharmatimes
November 25, 2020
Bristol Myers Squibb will pay $55m upfront to American life sciences company Schrödinger to access its drug discovery platform.
-
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
prnasia
November 10, 2020
Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, announced that it entered into a multi-target drug discovery agreement with Janssen ...
-
Axxam and Fujifilm Cellular Dynamics Enter Alliance
contractpharma
October 10, 2020
Axxam S.p.A. and Fujifilm Cellular Dynamics Inc. announced a strategic alliance to improve the drug discovery process.